Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steeve Provencher

Showing results (151-160 of 169) with videos related to

Pageof 17
Sort By:
American Journal of Respiratory and Critical Care Medicine|May 6, 2016
Role for Runt-related Transcription Factor 2 in Proliferative and Calcified Vascular Lesions in Pulmonary Arterial HypertensionGrégoire Ruffenach, Sophie Chabot, Virginie F Tanguay, et al.
Pulmonary Circulation|December 8, 2025
Transitioning From Parenteral Prostanoids to Oral Selexipag in Pulmonary Arterial Hypertension: A Multicenter Retrospective Cohort StudyBrandon Budhram, Sarah K Alrasheed, Moaaz Rashad, et al.
Circulation Research|June 4, 2019
Metabolic Syndrome Exacerbates Pulmonary Hypertension due to Left Heart DiseaseBenoît Ranchoux, Valérie Nadeau, Alice Bourgeois, et al.
Circulation|July 24, 2020
Identification of Long Noncoding RNA H19 as a New Biomarker and Therapeutic Target in Right Ventricular Failure in Pulmonary Arterial HypertensionJunichi Omura, Karima Habbout, Tsukasa Shimauchi, et al.
Science Translational Medicine|December 11, 2024
ATP citrate lyase drives vascular remodeling in systemic and pulmonary vascular diseases through metabolic and epigenetic changesYann Grobs, Charlotte Romanet, Sarah-Eve Lemay, et al.
Cell Reports. Medicine|February 11, 2025
Unraveling AURKB as a potential therapeutic target in pulmonary hypertension using integrated transcriptomic analysis and pre-clinical studiesSarah-Eve Lemay, Manon Mougin, Mélanie Sauvaget, et al.
Circulation|February 26, 2016
Potassium Channel Subfamily K Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial HypertensionFabrice Antigny, Aurélie Hautefort, Jolyane Meloche, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
Impaired Lung BCAA Metabolism Promotes Ferroptosis and Resultant Pulmonary Arterial Hypertension-Associated HepatopathyMadelyn J Blake, Jason Hong, Adam Brownstein, et al.
The Journal of Clinical Investigation|January 26, 2021
17β-Estradiol and estrogen receptor α protect right ventricular function in pulmonary hypertension via BMPR2 and apelinAndrea L Frump, Marjorie Albrecht, Bakhtiyor Yakubov, et al.
American Journal of Respiratory and Critical Care Medicine|May 3, 2019
Multicenter Preclinical Validation of BET Inhibition for the Treatment of Pulmonary Arterial HypertensionDiederik E Van der Feen, Kondababu Kurakula, Eve Tremblay, et al.
Pageof 17

Showing results (151-160 of 169) with videos related to

Sort By:
Pageof 17
American Journal of Respiratory and Critical Care Medicine|May 6, 2016
Role for Runt-related Transcription Factor 2 in Proliferative and Calcified Vascular Lesions in Pulmonary Arterial HypertensionGrégoire Ruffenach, Sophie Chabot, Virginie F Tanguay, et al.
Pulmonary Circulation|December 8, 2025
Transitioning From Parenteral Prostanoids to Oral Selexipag in Pulmonary Arterial Hypertension: A Multicenter Retrospective Cohort StudyBrandon Budhram, Sarah K Alrasheed, Moaaz Rashad, et al.
Circulation Research|June 4, 2019
Metabolic Syndrome Exacerbates Pulmonary Hypertension due to Left Heart DiseaseBenoît Ranchoux, Valérie Nadeau, Alice Bourgeois, et al.
Circulation|July 24, 2020
Identification of Long Noncoding RNA H19 as a New Biomarker and Therapeutic Target in Right Ventricular Failure in Pulmonary Arterial HypertensionJunichi Omura, Karima Habbout, Tsukasa Shimauchi, et al.
Science Translational Medicine|December 11, 2024
ATP citrate lyase drives vascular remodeling in systemic and pulmonary vascular diseases through metabolic and epigenetic changesYann Grobs, Charlotte Romanet, Sarah-Eve Lemay, et al.
Cell Reports. Medicine|February 11, 2025
Unraveling AURKB as a potential therapeutic target in pulmonary hypertension using integrated transcriptomic analysis and pre-clinical studiesSarah-Eve Lemay, Manon Mougin, Mélanie Sauvaget, et al.
Circulation|February 26, 2016
Potassium Channel Subfamily K Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial HypertensionFabrice Antigny, Aurélie Hautefort, Jolyane Meloche, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
Impaired Lung BCAA Metabolism Promotes Ferroptosis and Resultant Pulmonary Arterial Hypertension-Associated HepatopathyMadelyn J Blake, Jason Hong, Adam Brownstein, et al.
The Journal of Clinical Investigation|January 26, 2021
17β-Estradiol and estrogen receptor α protect right ventricular function in pulmonary hypertension via BMPR2 and apelinAndrea L Frump, Marjorie Albrecht, Bakhtiyor Yakubov, et al.
American Journal of Respiratory and Critical Care Medicine|May 3, 2019
Multicenter Preclinical Validation of BET Inhibition for the Treatment of Pulmonary Arterial HypertensionDiederik E Van der Feen, Kondababu Kurakula, Eve Tremblay, et al.
Pageof 17